 <h1>Pegaptanib ophthalmic Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to pegaptanib ophthalmic: intraocular solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, pegaptanib ophthalmic may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking pegaptanib ophthalmic:</p><p>
<i>More common</i>
</p><ul>
<li>Bladder pain</li>
<li>blindness</li>
<li>bloody eye</li>
<li>bloody or cloudy urine</li>
<li>blurred vision</li>
<li>burning, dry, or itching eyes</li>
<li>cough producing mucus</li>
<li>decreased vision or other changes in vision</li>
<li>difficult, burning, or painful urination</li>
<li>difficulty breathing</li>
<li>discharge, excessive tearing</li>
<li>disturbed color perception</li>
<li>double vision</li>
<li>drainage from eyes</li>
<li>eye pain</li>
<li>frequent urge to urinate</li>
<li>gradual loss of vision</li>
<li>halos around lights</li>
<li>itching of eyelid</li>
<li>looking through water</li>
<li>lower back or side pain</li>
<li>nausea</li>
<li>night blindness</li>
<li>overbright appearance of lights</li>
<li>painful irritation of the clear front part of the eye</li>
<li>redness, pain, swelling of eye, eyelid, or inner lining of eyelid</li>
<li>seeing flashes or sparks of light</li>
<li>seeing floating spots before the eyes</li>
<li>shortness of breath</li>
<li>sore eyes</li>
<li>swelling of the eye</li>
<li>tightness in chest</li>
<li>tunnel vision</li>
<li>vomiting</li>
<li>wheezing</li>
</ul><p>
<i>Less Common</i>
</p><ul>
<li>Bigger, dilated, or enlarged pupils (black part of the eye)</li>
<li>change in vision not present before treatment</li>
<li>chest pain</li>
<li>confusion</li>
<li>decrease in frequency of urination</li>
<li>decrease in urine volume</li>
<li>difficulty in passing urine (dribbling)</li>
<li>dizziness or lightheadedness</li>
<li>dry mouth</li>
<li>eye irritation</li>
<li>fatigue</li>
<li>feeling of constant movement of self or surroundings</li>
<li>flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>headache</li>
<li>hearing loss</li>
<li>inability to speak</li>
<li>increased hunger</li>
<li>increased sensitivity of eyes to light</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>loss of consciousness</li>
<li>numbness or tingling in face, arms, or legs</li>
<li>seeing floaters, veil or curtain appearing across part of vision</li>
<li>seizures</li>
<li>sensation of spinning</li>
<li>severe or sudden headache</li>
<li>slurred speech</li>
<li>stomachache</li>
<li>sweating</li>
<li>temporary blindness</li>
<li>trouble speaking, thinking, or walking</li>
<li>troubled breathing</li>
<li>unexplained weight loss</li>
<li>weakness in arm and/or leg on one side of the body, sudden and severe</li>
</ul><p>
<i>Incidence not determined</i>
</p><ul>
<li>Difficulty swallowing</li>
<li>fast heartbeat</li>
<li>hives</li>
<li>itching</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>skin rash</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of pegaptanib ophthalmic may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>blistering, burning, crusting, dryness, or flaking of skin</li>
<li>bruise</li>
<li>difficulty in moving</li>
<li>heartburn</li>
<li>indigestion</li>
<li>itching, scaling, severe redness, soreness, swelling of skin</li>
<li>muscle pain or stiffness</li>
<li>pain, swelling, or redness in joints</li>
<li>stomach discomfort, upset, or pain</li>
</ul><p>
<!-- end intraocular solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to pegaptanib ophthalmic: intravitreal solution</i></p><h3>Ocular</h3><p><b>Very common</b> (10% to 40%): Anterior chamber inflammation, blurred vision, cataract, conjunctival hemorrhage, corneal edema, eye discharge, eye irritation, eye pain, increased intraocular pressure, ocular discomfort, punctate keratitis, reduced visual acuity, visual disturbance, vitreous floaters, vitreous opacities</p>
<p><b>Common</b> (1% to 10%): Blepharitis, conjunctivitis, photopsia, vitreous disorder, allergic conjunctivitis, conjunctival edema, corneal abrasion, corneal deposits, corneal epithelium disorder, endophthalmitis, eye inflammation, eye swelling, eyelid irritation, meibomianitis, mydriasis, periorbital hematoma, retinal edema, vitreous hemorrhage</p>
<p><b>Uncommon</b> (0.1% to 1%): Retinal detachment, iatrogenic traumatic cataract, other adverse events related to the injection procedure<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% to 40%): Hypertension</p>
<p><b>Common</b> (1% to 10%): Chest pain<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Contact dermatitis, contusion<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Diabetes mellitus<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, nausea, dyspepsia, vomiting<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, urinary retention<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthritis, bone spur<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache, carotid artery occlusion, cerebrovascular accident, vertigo, transient ischemic attack<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Hearing loss<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Bronchitis, pleural effusion<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Angioedema and other anaphylaxis/anaphylactoid<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Macugen (pegaptanib ophthalmic)." OSI Pharmaceuticals Inc, Melville, NY. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about pegaptanib ophthalmic</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: anti-angiogenic ophthalmic agents</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Pegaptanib Intraocular &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Macugen</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Macular Degeneration</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to pegaptanib ophthalmic: intravitreal solution</i></p><h3>Ocular</h3><p><b>Very common</b> (10% to 40%): Anterior chamber inflammation, blurred vision, cataract, conjunctival hemorrhage, corneal edema, eye discharge, eye irritation, eye pain, increased intraocular pressure, ocular discomfort, punctate keratitis, reduced visual acuity, visual disturbance, vitreous floaters, vitreous opacities</p><p><b>Common</b> (1% to 10%): Blepharitis, conjunctivitis, photopsia, vitreous disorder, allergic conjunctivitis, conjunctival edema, corneal abrasion, corneal deposits, corneal epithelium disorder, endophthalmitis, eye inflammation, eye swelling, eyelid irritation, meibomianitis, mydriasis, periorbital hematoma, retinal edema, vitreous hemorrhage</p><p><b>Uncommon</b> (0.1% to 1%): Retinal detachment, iatrogenic traumatic cataract, other adverse events related to the injection procedure<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% to 40%): Hypertension</p><p><b>Common</b> (1% to 10%): Chest pain<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Contact dermatitis, contusion<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Diabetes mellitus<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, nausea, dyspepsia, vomiting<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, urinary retention<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthritis, bone spur<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache, carotid artery occlusion, cerebrovascular accident, vertigo, transient ischemic attack<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Hearing loss<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Bronchitis, pleural effusion<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Angioedema and other anaphylaxis/anaphylactoid<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Macugen (pegaptanib ophthalmic)." OSI Pharmaceuticals Inc, Melville, NY. </p><h2>More about pegaptanib ophthalmic</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: anti-angiogenic ophthalmic agents</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Pegaptanib Intraocular &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Macular Degeneration</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>